| LW |
Lamb Weston Holdings, Inc. |
Craps Jan Eli B |
|
2026-02-06 |
A - A |
128,571 |
0.00 |
0.00 |
128,571 |
| LW |
Lamb Weston Holdings, Inc. |
Craps Jan Eli B |
|
2026-02-06 |
A - A |
110,204 |
0.00 |
0.00 |
110,204 |
| LW |
Lamb Weston Holdings, Inc. |
Craps Jan Eli B |
|
2026-02-06 |
A - A |
750,000 |
0.00 |
0.00 |
750,000 |
| LW |
Lamb Weston Holdings, Inc. |
Crowley Michael Christopher |
|
2026-02-06 |
A - A |
13,680 |
0.00 |
0.00 |
25,100 |
| LW |
Lamb Weston Holdings, Inc. |
Crowley Michael Christopher |
|
2026-02-06 |
A - A |
99,668 |
0.00 |
0.00 |
99,668 |
| LW |
Lamb Weston Holdings, Inc. |
Crowley Michael Christopher |
|
2026-02-06 |
A - A |
99,668 |
0.00 |
0.00 |
99,668 |
| LW |
Lamb Weston Holdings, Inc. |
Crowley Michael Christopher |
|
2026-02-06 |
A - A |
85,430 |
0.00 |
0.00 |
85,430 |
| MRK |
Merck & Co., Inc. |
DeLuca Richard R. |
Officer
|
2026-02-06 |
S - D |
37,685 |
120.92 |
4,557,024.71 |
160,174 |
| JBHT |
HUNT J B TRANSPORT SERVICES INC |
Delco Albert Brad |
|
2026-02-06 |
S - D |
1,000 |
227.25 |
227,250.00 |
6,983 |
| RUM |
Rumble Inc. |
Devasini Giancarlo |
10% Owner
|
2026-02-06 |
P - A |
44,355 |
5.48 |
243,140.80 |
105,174,015 |
| BR |
BROADRIDGE FINANCIAL SOLUTIONS, INC. |
Duelks Robert N |
Director
|
2026-02-06 |
S - D |
253 |
192.60 |
48,727.80 |
20,815 |
| EWBC |
EAST WEST BANCORP INC |
CAMPBELL MOLLY |
Director
|
2026-02-06 |
S - D |
1,800 |
122.81 |
221,058.00 |
5,756 |
| EWBC |
EAST WEST BANCORP INC |
TEO GARY |
Officer
|
2026-02-06 |
S - D |
7,000 |
122.59 |
858,130.00 |
5,252 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - A |
2,387,705 |
0.00 |
0.00 |
2,387,705 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - A |
1,151,540 |
0.00 |
0.00 |
1,290,428 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - A |
2,155,765 |
0.00 |
0.00 |
2,294,653 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
10,000,000 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
7,807,026 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
2,502,252 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
796,380 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
530,920 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
5,289,322 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
3,526,215 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
303,360 |
0.00 |
0.00 |
0 |
| EIKN |
Eikon Therapeutics, Inc. |
Lux Total Opportunities, L.P. |
|
2026-02-06 |
C - D |
1,450,614 |
0.00 |
0.00 |
0 |